Enoximone

Enoximone
Clinical data
Routes of; administration	Intravenous
ATC code	C01CE03 (WHO) ;
Legal status
Legal status	UK: POM (Prescription only) ;
Pharmacokinetic data
Bioavailability	50% (oral)
Protein binding	85%
Metabolism	Hepatic oxidation
Elimination half-life	4 to 10 hours
Excretion	Renal (60 to 70%)
Identifiers
	IUPAC name 4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-; dihydroimidazol-2-one;
CAS Number	77671-31-9;
PubChem CID	53708;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C12H12N2O2S
Molar mass	248.302 g/mol
3D model (JSmol)	Interactive image;
	SMILES CSc1ccc(cc1)C(=O)C2=C(C)NC(=O)N2;

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.

Clinical data

Routes of administration	Intravenous
ATC code	C01CE03 (WHO)
Legal status
Legal status	UK: POM (Prescription only)
Pharmacokinetic data
Bioavailability	50% (oral)
Protein binding	85%
Metabolism	Hepatic oxidation
Elimination half-life	4 to 10 hours
Excretion	Renal (60 to 70%)
Identifiers
IUPAC name 4-methyl-5-(4-methylsulfanylbenzoyl)-1,3- dihydroimidazol-2-one
CAS Number	77671-31-9
PubChem CID	53708
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₂H₁₂N₂O₂S
Molar mass	248.302 g/mol
3D model (JSmol)	Interactive image
SMILES CSc1ccc(cc1)C(=O)C2=C(C)NC(=O)N2